newsfilter
← Latest News
GlobeNewswire·

Decibel Therapeutics Appoints Kevin F. McLaughlin to its Board of Directors

BOSTON, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Decibel Therapeutics (NASDAQ:DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and